Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Hypoactive Sexual Desire Disorder
Interventions
DRUG

Testosterone

patch, 300 mcg/day testosterone, patch changed every 3-4 days, 24 weeks

DRUG

Placebo

patch, placebo, patch changed every 3-4 days, 24 weeks

Trial Locations (31)

2031

Research Facility, Randwick

2072

Research Facility, Gordon

2131

Research Facility, Ashfield

3181

Research Facility, Prahran

5065

Research Facility, Dulwich

6009

Research Facility, Nedlands

20357

Research Facility, Hamburg

48149

Research Facility, Münster

D-79085

Research Facility, Freiburg

H1T 1P6

Research Facility, Montreal

G1S 2L6

Research Facility, Québec

D-52074

Research Facility, Aachen

OX3 9DU

Site Facility, Headington

Research Facility, Headington

B91 2JL

Research Facility, Solihull

CV9 1EU

Research Facility, Atherstone

Research Facility, Warks

CV7 8LA

Research Facility, Coventry

DN1 2ET

Research Facility, Doncaster

SG6 4TS

Research Facility, Herts

LE1 5WW

Research Facility, Leicester

LW1 5WW

Research Facility, Leicester

WS14 9LH

Research Facility, Lichfield

NW8 9NH

Research Facility, London

SE1 9RT

Research Facility, London

SW1W 8RH

Research Facility, London

W12 0HS

Research Facility, London

W1G 7JW

Research Facility, London

W2 1NY

Research Facility, London

PL4 8QU

Research Facility, Plymouth

M8 8HD

Research Facility, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00384046 - Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen | Biotech Hunter | Biotech Hunter